More importantly, our study also showed that blockade of EUDAL/EGFR/STAT3/autophagy signaling can sensitize tumor cells to chemotherapy and that the EUDAL/EGFR/STAT3/autophagy signaling status can predict the drug response in patients with oral cancer. This evidence concerns the gene EGFR and neoplasm.